CYTOSINE-ARABINOSIDE (CA) IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) - A 10 YEAR EXPERIENCE

被引：0
作者：
HESS, CE [1 ]
ZIRKLE, JW [1 ]
机构：
[1] UNIV VIRGINIA,DEPT MED,CHARLOTTESVILLE,VA 22903
来源：
CLINICAL RESEARCH | 1980年 / 28卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：A313 / A313
页数：1
相关论文
共 50 条
  • [41] INTERMEDIATE-DOSE OF CYTOSINE-ARABINOSIDE FOR CONSOLIDATION CHEMOTHERAPY IN ELDERLY PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
    OHNO, Y
    TANIGUCHI, S
    YAMASAKI, K
    SHIBUYA, T
    ASAYAMA, R
    TAKITA, A
    HARADA, M
    NIHO, Y
    CANCER RESEARCH THERAPY & CONTROL, 1993, 3 (04): : 289 - 295
  • [42] SECONDARY ACUTE NONLYMPHOCYTIC LEUKEMIA - CYTOGENETIC STUDIES AND RESPONSE TO THERAPY WITH LARGE DOSES OF CYTOSINE-ARABINOSIDE
    MARINELLO, MJ
    PREISLER, HD
    EARLY, A
    RAZA, A
    STEIN, AM
    BROWMAN, GG
    VLAHIDES, G
    BANNERMAN, RM
    AMERICAN JOURNAL OF HUMAN GENETICS, 1982, 34 (06) : A74 - A74
  • [43] CHEMOTHERAPY FOR ACUTE NONLYMPHOCYTIC LEUKEMIA WITH LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C)
    LIN, SF
    LIU, HW
    CHEN, TP
    ACTA HAEMATOLOGICA JAPONICA, 1990, 53 (01): : 45 - 50
  • [44] CYTOSINE-ARABINOSIDE TRANSPORT IN ACUTE-LEUKEMIA
    WILEY, JS
    JONES, SP
    SAWYER, WH
    PATERSON, ARP
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1981, 8 (04) : 368 - 368
  • [45] CYTOSINE-ARABINOSIDE, DAUNORUBICIN +/-VP16-213 (73 VS 737) AS INITIAL INDUCTION THERAPY IN ADULT ACUTE NONLYMPHOCYTIC LEUKEMIA (ANLL) - A STUDY OF THE AUSTRALIAN LEUKEMIA STUDY-GROUP
    BISHOP, JF
    LOWENTHAL, RM
    JOSHUA, DE
    MATTHEWS, JP
    WHITESIDE, MG
    KRONENBERG, H
    TODD, D
    COBCROFT, R
    MEDICAL AND PEDIATRIC ONCOLOGY, 1987, 15 (03): : 134 - 134
  • [46] RESULTS OF A RANDOMIZED TRIAL COMPARING IDARUBICIN AND CYTOSINE-ARABINOSIDE WITH DAUNORUBICIN AND CYTOSINE-ARABINOSIDE IN ADULT PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA
    BERMAN, E
    HELLER, G
    SANTORSA, J
    MCKENZIE, S
    GEE, T
    KEMPIN, S
    GULATI, S
    ANDREEFF, M
    KOLITZ, J
    GABRILOVE, J
    REICH, L
    MAYER, K
    KEEFE, D
    TRAINOR, K
    SCHLUGER, A
    PENENBERG, D
    RAYMOND, V
    OREILLY, R
    JHANWAR, S
    YOUNG, C
    CLARKSON, B
    BLOOD, 1991, 77 (08) : 1666 - 1674
  • [47] HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ADULT ACUTE MYELOGENOUS LEUKEMIA
    NEMET, D
    LABAR, B
    BOGDANIC, V
    HAUPTMAN, E
    JAKSIC, B
    MINIGO, H
    SERTIC, D
    MRSIC, M
    PAVLETIC, Z
    KOVACEVIC, J
    ZUPANCICSALEK, S
    RADMAN, I
    BONE MARROW TRANSPLANTATION, 1989, 4 : 42 - 44
  • [48] CYTOSINE-ARABINOSIDE (NSC-63878) AND DAUNORUBICIN (NSC-83142) THERAPY IN ACUTE NONLYMPHOCYTIC LEUKEMIA
    YATES, JW
    WALLACE, HJ
    ELLISON, RR
    HOLLAND, JF
    CANCER CHEMOTHERAPY REPORTS PART 1, 1973, 57 (04): : 485 - 488
  • [49] CYTOSINE-ARABINOSIDE MODULATION OF THE MITOTIC INDEX IN TREATMENT OF ADULT ACUTE-LEUKEMIA
    MACKINNEY, AA
    FLYNN, B
    AMERICAN JOURNAL OF HEMATOLOGY, 1978, 5 (02) : 93 - 99
  • [50] INFUSIONAL CYTOSINE-ARABINOSIDE ADMINISTRATION FOR THE TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA
    THOMAS, X
    ARCHIMBAUD, E
    BULLETIN DU CANCER, 1995, 82 (11) : 911 - 922
12345